In the United States, there has never been a greater number of people suffering from addiction. According to addiction trends from the National Institute on Drug Abuse., 49.2% of Americans had tried illicit drugs at least once during their lifetime. The most commonly abused substances are heroin, cocaine and pain relievers, and alcohol. A heroin overdose claimed the lives of approximately 15,000 people in 2018. 31,000 people also died in the same year from synthetic opioids. Making matters more difficult, many people who have substance use disorders (SUDs) also have mental illnesses.
The percentage of adults aged 12 and older who reported using illicit drugs at least once during their lifetime increased slightly between 2016 and 2018, from 48.5% up to 49.2%.
The percentage of adults 12 years old or older who reported using illicit drugs in the last year had increased from 18% to 19% to 19.4%, from 2016, to 2017, and to 2018.
A slight increase in the number of people aged 12 and older who reported using an illicit drug within the past month has also been noted: :1
The percentage of teens who admitted to using illicit drugs at least once during their lives has barely increased between 2016 and 2018. It was 23% to 23.9%.
Between 2016 and 2018, the percentage teenagers who reported using illicit drugs during the previous year has increased from 15.8% to 16.3%, to 16.7%.
The percentage of teens who reported using an illicit drug in recent months has also remained relatively stable:1
The percentage of young adults who reported using illicit drugs at least once during their lifetime decreased slightly between 2016 and 2018, from 56.3% to 55.6%. 1 This percentage still means that half of young adults had used an illegal drug at some point in their lives.
The percentage of young adults who reported using illicit drugs during the last year has varied from 37.7% to 39.4%, and back down to 38.7% between 2016 and 2018.1
There has been a slight variation in the number of young adults who reported that they had used illicit drugs within the past month:
These percentages mean that an average of 1 in four young adults has used an illicit drug in the past month.
Between 2016 and 2018, the percentage of adults aged 26 or older who said they used illicit drugs at least once in their lifetime barely increased, from 50.2% to 51.2%.1
From 2016 to 2018, the percentage of adults who said they used illicit drugs in the past year slightly increased, from 15% to 16.1% to 16.7%.1
The number of adults who said they used an illicit drug in the last month is also creeping towards 10%:1
In 2019, people ages 18-25 were most likely to be misusing a prescription pain reliever, followed by adults older than 25.
In 2019, young adults were more likely than other age groups to be abusing a tranquilizer or sedative.
Among people aged 12 or older in 2019, 1.8% misused prescription stimulants in the past year. These estimates in 2019 were lower than those in 2016 and 2017. 1.2% of adults in 2019 misused prescription stimulants in the past year. The numbers were similar from 2015 to 2019.
1.7% of adolescents in 2019 misused prescription stimulants in the past year. The statistics were similar from 2015 to 2019. Among young adults, percentages for the past year misuse of prescription stimulants declined from 7.5% in 2016 to 5.8% in 2019.2
In 2018, around 31,000 deaths that involve synthetic opioids happened in the United States. The overdose deaths due to synthetic opioids increased by 10% from 2017 to 2018.
The number of deaths involving synthetic opioids other than methadone (mainly fentanyl) continued to increase in 2019, with 36,359 reported overdose deaths.
Since 2012, the number of overdose deaths involving psychostimulants (primarily methamphetamine) has increased each year, with 16,167 deaths in 2019.3
Overdose deaths involving cocaine increased from 3,822 in 1999 to 15,883 in 2019. The main driver of cocaine-related overdose deaths is the mixing of cocaine with synthetic opioids.3
According to estimations, 41 people died every day from overdoses involving prescription opioids in 2018. The number of overdose deaths that involve prescription opioids dropped by 13.5% from 2017 to 2018.
In 2019, the number of overdose deaths was 14,139.3
In 2018, roughly 15,000 people died from a heroin overdose in the United States. Compared to heroin-related overdose deaths in 2017, the number decreased by 4.1%4
There were 14,019 deaths involving heroin reported in 2019.
Drug overdose deaths involving benzodiazepines increased from 1,135 in 1999 to 11,537 in 2017. Between 2017 and 2019, deaths declined to 9,711.
Traditionally, Atlanta has had the highest rates of methamphetamine use than any other major US city east of the Mississippi River.
In 2016, there were 379 deaths where methamphetamine was present at the time of death, compared to 285 in 2015.5
In 2017, the top drugs found in decedents in the George Medical Examiner’s reports were alprazolam (576), methamphetamine (479), and oxycodone (469).6
The number of statewide decedents who tested positive for methamphetamine at the time of death reached an all-time high in 2018 with 614 deaths. According to reports, Atlanta’s methamphetamine supply was being mixed with increasing amounts of fentanyl, an addition that can be dangerously undetected.7
In 2019, the number of deaths involving methamphetamines dropped by 10.1%.8
In 2019, Atlanta-based drug calls to Georgia Poison Control Center for heroin reached an all-time high, with 107 calls being made. It was an increase from 2018 when the number of heroin-related drug calls was 100.9
That same year, there were 186 drug calls related to opiates, another all-time high.
In 2019, the Georgia Poison Control Center received 92 meth-related drug calls from Atlanta, compared to 72 drug calls in 2018.9
In 2019, the number of alprazolam deaths and other benzodiazepines was the lowest since 2008. All major drug indicators suggest a decrease in benzodiazepine use in metro Atlanta, compared to the previous 5-6 years. Benzodiazepines continue to be the one drug most often abused by females, and increased use among persons younger than 26 years old is reported.9
People who have post-traumatic stress disorder (PTSD) are at a higeher risk of developing an addiction. They may abuse alcohol or drugs in a misguided attempt to reduce their feelings of anxiety, but substance abuse can worsen their PTSD symptoms. In fact, roughly 50% of people seeking treatment for substance use also meet the criteria for PTSD.10
Addiction and depression have a close relationship. Many people living with depression often self-medicate with different medications in an attempt to break free from the negative symptoms of the illness. One study has shown that around one-third of people with a major depressive disorder also have a substance use disorder. Unfortunately, the comorbidity can lead to a higher risk of suicide and greater social and personal impairment.11
Addiction can increase the risk of developing anxiety or can make pre-existing symptoms worse. Stimulant drugs are most commonly related to causing and worsening the symptoms of anxiety, as they increase activity in the brain.11
Moreover, people with social anxiety may turn to alcohol or drugs to feel more comfortable and relaxed in social situations. Although drugs and alcohol can bring temporary relief, they can also intensify anxiety a few hours later or the next day.
According to statistics, around 60% of individuals with bipolar disorder abuse alcohol or drugs.12
Bipolar disorder and addiction are a dangerous combination. Each condition can worsen the symptoms and severity of the other. The co-occurrence increases the risk of mood swings, depression, violence, and suicide.
Table of Contents
Gregory Ng is the CEO of Brooks Bell. In his nearly 25 years in marketing, Greg has created innovative solutions leading to digital and cognitive transformations for the biggest high-tech, retail and financial brands in the world. Greg adds knowledge in marketing strategy, content production, and brand awareness to the AHV advisory board.
Hunt Broyhill holds several positions within the Broyhill family offices and serves as President, Chairman, and Chief Executive Officer of BMC Fund and Chief Executive Officer of Broyhill Asset Management. Hunt brings valuable experience in capital allocation, real estate, and investor relations to the AHV advisory board.
Alan Hughes was formerly the Executive Vice President and Chief Operating Officer at Blue Cross and Blue Shield of North Carolina. In addition to BCBS, Alan held officer positions in both operations and technology at GE Commercial Finance, Deutsche Bank, and American Express. Alan brings a unique combination of efficient process design and technological problem solving to the AHV advisory board.
Lynn is the CEO of Broadstep. Previously, Lynn held various roles in both healthcare and finance where she oversaw multi-site, multi-state organizations within primary care, acute and chronic services, hospitals, and pharmacies. Lynn brings valuable experience in healthcare leadership, recruiting, and growth strategy to the AHV advisory board.
John Roos is the retired Senior Vice President and Chief Growth Officer for Blue Cross and Blue Shield of North Carolina. Under Roos’s tenure, the company’s revenue grew from $1.5 billion to $9.5 billion, while adding 1 million members. John brings valuable experience in growth strategy, enterprise sales, and provider contracting to the AHV advisory board.
Dr. Hendree Jones is the Executive Director of UNC-Horizons and an internationally recognized expert in behavioral and pharmacologic treatments for pregnant women and their children. Dr. Jones has received continuous funding from the National Institutes of Health since 1994 and has over 200 peer-reviewed publications. Dr. Jones is an advisor to the UN, WHO, SAMHSA, ASAM, and ACOG through which she consults throughout the United States and internationally. Dr. Jones brings valuable experience in grant writing, research, and healthcare administration to the AHV advisory board.
Brad is the CEO Emeritus for BCBSNC and Chair of the BCBSNC Foundation. He served as Gov. Jim Hunt’s general counsel and is a past chair of the UNC Board of Governors. Brad serves on numerous public and private boards and is a lifelong North Carolinian with degrees from Appalachian State, Wake Forest, and Duke. He brings valuable experience in healthcare, law, higher education, and politics.
Jake Summers is a passionate entrepreneur who is dedicated to bringing the energy of change to existing healthcare business models and making higher quality healthcare more accessible. Jake co-founded a mango farming/export company in Cambodia and serves as an advisor for a number of small businesses. Jake is the co-founder of Advaita Integrated Medicine and is the Development Director and a Partner of Green Hill.
Tripp Johnson is a serial healthcare entrepreneur who’s dedicated his post-military professional life to serving young adults. He is the co-founder of Advaita Integrated Medicine, Advaita Health Ventures, and Green Hill Recovery. Tripp is passionate about making quality healthcare more affordable and accessible through innovative business models and technology-focused solutions.